CVE-2021-32858

Public Exploit
esdoc-publish-html-plugin vulnerable to Cross-site Scripting

Description

esdoc-publish-html-plugin is a plugin for the document maintenance software ESDoc. TheHTML sanitizer in esdoc-publish-html-plugin 1.1.2 and prior can be bypassed which may lead to cross-site scripting (XSS) issues. There are no known patches for this issue.

Category

6.1
CVSS
Severity: Medium
CVSS 3.1 •
EPSS 0.11%
Third-Party Advisory github.com Third-Party Advisory github.com
Affected: esdoc esdoc-publish-html-plugin
Published at:
Updated at:

References

Link Tags
https://securitylab.github.com/advisories/GHSL-2021-1034_esdoc-publish-html-plugin/ third party advisory exploit
https://github.com/esdoc/esdoc-plugins/blob/2de5022baa569785a189056a99acd1d7ca8284b7/esdoc-publish-html-plugin/src/Builder/util.js#L80 third party advisory patch

Frequently Asked Questions

What is the severity of CVE-2021-32858?
CVE-2021-32858 has been scored as a medium severity vulnerability.
How to fix CVE-2021-32858?
To fix CVE-2021-32858, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2021-32858 being actively exploited in the wild?
It is possible that CVE-2021-32858 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2021-32858?
CVE-2021-32858 affects esdoc esdoc-publish-html-plugin.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.